FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Maxygen

Sort
E.g., 2013-05-26
E.g., 2013-05-26
Enter a comma separated list of user names.

Maxygen, Inc (Nasdaq:MAXY) announced that its Board of Directors has approved an increase to the company's current stock repurchase program from $10.0 million to $20.0 million. The repurchase program expires on December 31, 2011.

Maxygen, Inc., a biopharmaceutical company, focuses on developing improved versions of protein drugs.

**********************************

Power3 Medical Products, Inc. (OTC.BB:PWRM) a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States.

HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, recently announced revenues of $13.8 million for the third quarter ended September 30, 2010.

Cablevision Systems Corporation (NYSE:CVC) - Fox, owned by News Corp., and Cablevision Systems Corp. stated previous talks did not bring a new agreement on how much Cablevision will pay to carry the network.

ADVERTISE WITH US